Integrin αDβ2 is dynamically expressed by inflamed macrophages and alters the natural history of lethal systemic infections

Journal of Immunology

Volumn 180, Issue 1, 2008, Pages 590-600

  Miyazaki, Yasunari ^a,d   Bunting, Michaeline ^a,e   Stafforini, Diana M ^a,b   Harris, Estelle S ^a   McIntyre, Thomas M ^a,f   Prescott, Stephen M ^a,b,g   Frutuoso, Valber S ^c   Amendoeira, Fabio C ^c   Nascimento, Danielle De Oliveira ^c   Vieira de Abreu, Adriana ^c   Weyrich, Andrew S ^a   Castro Faria Neto, Hugo C ^c   Zimmerman, Guy A ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e INVITROGEN CORPORATION   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTEGRIN; INTEGRIN ALPHAD BETA2; UNCLASSIFIED DRUG; ALPHA INTEGRIN; CD11 ANTIGEN; INTEGRIN ALPHAD, MOUSE;

ANATOMICAL VARIATION; ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL POPULATION; CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; FATALITY; GENE DELETION; HOST RESISTANCE; IN VITRO STUDY; LEUKOCYTE; LIVER; MACROPHAGE; MORTALITY; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS REGULATION; PROVOCATION TEST; SALMONELLA; SEPSIS; SPLEEN; SURVIVAL RATE; WILD TYPE; ANIMAL; GENETICS; IMMUNOLOGY; INFLAMMATION; MACROPHAGE ACTIVATION; MALARIA; METABOLISM; MOUSE MUTANT;

ANIMALS; ANTIGENS, CD11; CYTOKINES; INFLAMMATION; INTEGRIN ALPHA CHAINS; LIVER; MACROPHAGE ACTIVATION; MACROPHAGES; MALARIA; MICE; MICE, KNOCKOUT; PLASMODIUM BERGHEI; SALMONELLA; SEPSIS; SPLEEN;

EID: 40449129551     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.1.590     Document Type: Article

References (62)

1. Harris, E. S., T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman. 2000. The leukocyte integrins. J. Biol. Chem. 275: 23409-23412.
2. 2 integrins and selectin ligands. Curr. Opin. Hematol. 9: 30-35.
3. Hynes, R. O. 2002. Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687.
4. Scharffetter-Kochanek, K., H. Lu, K. Norman, N. van Nood, F. Munoz, S. Grabbe, M. McArthur, I. Lorenzo, S. Kaplan, K. Ley, et al. 1998. Spontaneous skin ulceration and defective T cell function in CD18 null mice. J. Exp. Med. 188: 119-131.
5. Etzioni, A., C. M. Doerschuk, and J. M. Harlan. 1999. Of man and mouse: leukocyte and endothelial adhesion molecule deficiencies. Blood 94: 3281-3288.
6. Lee, S. H., and D. B. Corry. 2004. Homing alone? CD18 in infectious and allergic disease. Trends Mol. Med. 10: 258-262.
7. Yonekawa, K., and J. M. Harlan. 2005. Targeting leukocyte integrins in human diseases. J. Leukocyte Biol. 77: 129-140.
8. 2, binds preferentially to ICAM-3. Immunity 3: 683-690.
9. 2 integrin is expressed on human eosinophils and functions as an alternative ligand for vascular cell adhesion molecule 1 (VCAM-1). J. Exp. Med. 188: 2187-2191.
10. 2 binds VCAM-1: evidence for a binding interface between I domain and VCAM-1. J. Immunol. 163: 1984-1990.
11. Yakubenko, V. P., S. P. Yadav, and T. P. Ugarova. 2006. Integrin αDβ2, an adhesion receptor up-regulated on macrophage foam cells, exhibits multiligandbinding properties. Blood 107: 1643-1650.
12. d/ CD18, a novel leukointegrin: comparison with other integrins and their ligands. Arthritis Rheum. 39: 1913-1921.
13. Noti, J. D. 2002. Expression of the myeloid-specific leukocyte integrin gene CD11d during macrophage foam cell differentiation and exposure to lipoproteins. Int. J. Mol. Med. 10: 721-727.
14. d in IgG immune complex-induced rat lung injury. J. Immunol. 160: 1014-1020.
15. Oatway, M. A., Y. Chen, J. C. Bruce, G. A. Dekaban, and L. C. Weaver. 2005. Anti-CD11d integrin antibody treatment restores normal serotonergic projections to the dorsal, intermediate, and ventral horns of the injured spinal cord. J. Neurosci. 25: 637-647.
16. Wu, H., J. R. Rodgers, X. Y. Perrard, J. L. Perrard, J. E. Prince, Y. Abe, B. K. Davis, G. Dietsch, C. W. Smith, and C. M. Ballantyne. 2004. Deficiency of CD11b or CD11d results in reduced staphylococcal enterotoxin-induced T cell response and T cell phenotypic changes. J. Immunol. 173: 297-306.
17. Bunting, M., K. E. Bernstein, J. M. Greer, M. R. Capecchi, and K. R. Thomas. 1999. Targeting genes for self-excision in the germ line. Genes Dev. 13: 1524-1528.
18. Mansour, S. L., K. R. Thomas, and M. R. Capecchi. 1988. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336: 348-352.
19. Schwenk, F., U. Baron, and K. Rajewsky. 1995. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23: 5080-5081.
20. McKnight, A. J., and S. Gordon. 1998. Membrane molecules as differentiation antigens of murine macrophages. Adv. Immunol. 68: 271-314.
21. Cao, Y., K. J. Murphy, T. M. McIntyre, G. A. Zimmerman, and S. M. Prescott. 2000. Expression of fatty acid-CoA ligase 4 during development and in brain. FEBS Lett. 467: 263-267.
22. + T cells and intestinal intraepithelial T cells in IFN-regulatory factor-1-deficient mice. J. Immunol. 166: 6509-6513.
23. Kessel, J. M., J. Hayflick, A. S. Weyrich, P. A. Hoffman, M. Gallatin, T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman. 1998. Coengagement of ICAM-3 and Fc receptors induces chemokine secretion and spreading by myeloid leukocytes. J. Immunol. 160: 5579-5587.
24. Hoffman-Liebermann, B., and D. A. Liebermann. 1991. Interleukin-6- and leukemia inhibitory factor-induced terminal differentiation of myeloid leukemia cells is blocked at an intermediate stage by constitutive c-myc. Mol. Cell. Biol. 11: 2375-2381.
25. 3 regulates synthesis of proteins in activated human platelets. J. Cell Biol. 144: 175-184.
26. Stamper, H. B., Jr., and J. J. Woodruff. 1976. Lymphocyte homing into lymph nodes: in vitro demonstration of the selective affinity of recirculating lymphocytes for high-endothelial venules. J. Exp. Med. 144: 828-833.
27. 1 integrin. Nature 356: 63-66.
28. Cordeiro, R. S., F. Q. Cunha, J. A. Filho, C. A. Flores, H. N. Vasconcelos, and M. A. Martins. 1983. Plasmodium berghei: physiopathological changes during infections in mice. Ann. Trop. Med. Parasitol. 77: 455-465.
29. Adachi, K., H. Tsutsui, S. Kashiwamura, E. Seki, H. Nakano, O. Takeuchi, K. Takeda, K. Okumura, L. Van Kaer, H. Okamura, et al. 2001. Plasmodium berghei infection in mice induces liver injury by an IL-12- and Toll-like receptor/ myeloid differentiation factor 88-dependent mechanism. J. Immunol. 167: 5928-5934.
30. + lymphocyte subpopulation in peripheral blood. J. Immunol. 155: 35-44.
31. Geissmann, F., S. Jung, and D. R. Littman. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82.
32. Randolph, G. J., S. Beaulieu, S. Lebecque, R. M. Steinman, and W. A. Muller. 1998. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282: 480-483.
33. Van der Laan, L. J., E. A. Dopp, R. Haworth, T. Pikkarainen, M. Kangas, O. Elomaa, C. D. Dijkstra, S. Gordon, K. Tryggvason, and G. Kraal. 1999. Regulation and functional involvement of macrophage scavenger receptor MARCO in clearance of bacteria in vivo. J. Immunol. 162: 939-947.
34. Mebius, R. E., and G. Kraal. 2005. Structure and function of the spleen. Nat. Rev. Immunol. 5: 606-616.
35. Yadava, A., S. Kumar, J. A. Dvorak, G. Milon, and L. H. Miller. 1996. Trafficking of Plasmodium chabaudi adami-infected erythrocytes within the mouse spleen. Proc. Natl. Acad. Sci. USA 93: 4595-4599.
36. Urban, B. C., and D. J. Roberts. 2002. Malaria, monocytes, macrophages, and myeloid dendritic cells: sticking of infected erythrocytes switches off host cells. Curr. Opin. Immunol. 14: 458-465.
37. de Souza, J. B., and E. M. Riley. 2002. Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infect. 4: 291-300.
38. Hunt, N. H., and G. E. Grau. 2003. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 24: 491-499.
39. Schofield, L. 2007. Intravascular infiltrates and organ-specific inflammation in malaria pathogenesis. Immunol. Cell Biol. 85: 130-137.
40. + T lymphocyte-mediated loss of marginal metallophilic macrophages following infection with Plasmodium chabaudi chabaudi AS. J. Immunol. 177: 2518-2526.
41. Yoshimoto, T., Y. Takahama, C. R. Wang, T. Yoneto, S. Waki, and H. Nariuchi. 1998. A pathogenic role of IL-12 in blood-stage murine malaria lethal strain Plasmodium berghei NK65 infection. J. Immunol. 160: 5500-5505.
42. Gordon, S. 2002. Alternative activation of macrophages. Nat. Immunol. 3: 23-35.
43. Noel, W., G. Raes, G. Hassanzadeh Ghassabeh, P. De Baetselier, and A. Beschin. 2004. Alternatively activated macrophages during parasite infections. Trends Parasitol. 20: 126-133.
44. Wijburg, O. L., C. P. Simmons, N. van Rooijen, and R. A. Strugnell. 2000. Dual role for macrophages in vivo in pathogenesis and control of murine Salmonella enterica var. Typhimurium infections. Eur. J. Immunol. 30: 944-953.
45. -/- mice. Infect. Immun. 73: 7637-7643.
46. Ghosh, S., A. A. Chackerian, C. M. Parker, C. M. Ballantyne, and S. M. Behar. 2006. The LFA-1 adhesion molecule is required for protective immunity during pulmonary Mycobacterium tuberculosis infection. J. Immunol. 176: 4914-4922.
47. Grau, G. E., P. Pointaire, P. F. Piguet, C. Vesin, H. Rosen, I. Stamenkovic, F. Takei, and P. Vassalli. 1991. Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria. Eur. J. Immunol. 21: 2265-2267.
48. Falanga, P. B., and E. C. Butcher. 1991. Late treatment with anti-LFA-1 (CD11a) antibody prevents cerebral malaria in a mouse model. Eur. J. Immunol. 21: 2259-2263.
49. Favre, N., C. Da Laperousaz, B. Ryffel, N. A. Weiss, B. A. Imhof, W. Rudin, R. Lucas, and P. F. Piguet. 1999. Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect. 1: 961-968.
50. Urban, B. C., T. T. Hien, N. P. Day, N. H. Phu, R. Roberts, E. Pongponratn, M. Jones, N. T. Mai, D. Bethell, G. D. Turner, et al. 2005. Fatal Plasmodium falciparum malaria causes specific patterns of splenic architectural disorganization. Infect. Immun. 73: 1986-1994.
51. Weiss, L. 1989. Mechanisms of splenic control of murine malaria: cellular reactions of the spleen in lethal (strain 17XL) Plasmodium yoelii malaria in BALB/c mice, and the consequences of pre-infective splenectomy. Am. J. Trop. Med. Hyg. 41: 144-160.
52. Evans, K. J., D. S. Hansen, N. van Rooijen, L. A. Buckingham, and L. Schofield. 2006. Severe malarial anemia of low parasite burden in rodent models results from accelerated clearance of uninfected erythrocytes. Blood 107: 1192-1199.
53. McDevitt, M. A., J. Xie, G. Shanmugasundaram, J. Griffith, A. Liu, C. McDonald, P. Thuma, V. R. Gordeuk, C. N. Metz, R. Mitchell, et al. 2006. A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia. J. Exp. Med. 203: 1185-1196.
54. Yoshida, H., K. Kawane, M. Koike, Y. Mori, Y. Uchiyama, and S. Nagata. 2005. Phosphatidylserine-dependent engulfment by macrophages of nuclei from erythroid precursor cells. Nature 437: 754-758.
55. Soni, S., S. Bala, B. Gwynn, K. E. Sahr, L. L. Peters, and M. Hanspal. 2006. Absence of erythroblast macrophage protein (Emp) leads to failure of erythroblast nuclear extrusion. J. Biol. Chem. 281: 20181-20189.
56. Rosales, C., and R. L. Juliano. 1995. Signal transduction by cell adhesion receptors in leukocytes. J. Leukocyte Biol. 57: 189-198.
57. Marth, T., and B. L. Kelsall. 1997. Regulation of interleukin-12 by complement receptor 3 signaling. J. Exp. Med. 185: 1987-1995.
58. Mosser, D. M., and C. L. Karp. 1999. Receptor mediated subversion of macrophage cytokine production by intracellular pathogens. Curr. Opin. Immunol. 11: 406-411.
59. Sutterwala, F. S., G. J. Noel, R. Clynes, and D. M. Mosser. 1997. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J. Exp. Med. 185: 1977-1985.
60. Jacobs, T., T. Plate, I. Gaworski, and B. Fleischer. 2004. CTLA-4-dependent mechanisms prevent T cell induced-liver pathology during the erythrocyte stage of Plasmodium berghei malaria. Eur. J. Immunol. 34: 972-980.
61. Kincy-Cain, T., J. D. Clements, and K. L. Bost. 1996. Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin. Infect. Immun. 64: 1437-1440.
62. Stevenson, M. M., and E. M. Riley. 2004. Innate immunity to malaria. Nat. Rev. Immunol. 4: 169-180.